Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

References for PMC Articles for PubMed (Select 20673549)

1.

Betting on change: modeling transitional probabilities to guide therapy development for opioid dependence.

Carpenter KM, Jiang H, Sullivan MA, Bisaga A, Comer SD, Raby WN, Brooks AC, Nunes EV.

Psychol Addict Behav. 2009 Mar;23(1):47-55. doi: 10.1037/a0013049.

3.

A comparison of oral and implant naltrexone outcomes at 12 months.

Colquhoun R, Tan DY, Hull S.

J Opioid Manag. 2005 Nov-Dec;1(5):249-56.

PMID:
17319558
4.

Behavioral therapy to augment oral naltrexone for opioid dependence: a ceiling on effectiveness?

Nunes EV, Rothenberg JL, Sullivan MA, Carpenter KM, Kleber HD.

Am J Drug Alcohol Abuse. 2006;32(4):503-17.

PMID:
17127538
5.

Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.

Johansson BA, Berglund M, Lindgren A.

Addiction. 2006 Apr;101(4):491-503. Review.

PMID:
16548929
6.

Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial.

Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K, Dackis C, O'Brien CP.

Arch Gen Psychiatry. 2006 Feb;63(2):210-8.

7.

Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence.

Carreño JE, Alvarez CE, Narciso GI, Bascarán MT, Díaz M, Bobes J.

Addict Biol. 2003 Dec;8(4):429-38.

PMID:
14690879
9.

Behavioral family counseling and naltrexone for male opioid-dependent patients.

Fals-Stewart W, O'Farrell TJ.

J Consult Clin Psychol. 2003 Jun;71(3):432-42.

PMID:
12795568
10.

Behavioral naltrexone therapy: an integrated treatment for opiate dependence.

Rothenberg JL, Sullivan MA, Church SH, Seracini A, Collins E, Kleber HD, Nunes EV.

J Subst Abuse Treat. 2002 Dec;23(4):351-60.

PMID:
12495797
11.

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans.

Comer SD, Collins ED, Kleber HD, Nuwayser ES, Kerrigan JH, Fischman MW.

Psychopharmacology (Berl). 2002 Feb;159(4):351-60. Epub 2001 Nov 1.

12.

Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.

Carroll KM, Ball SA, Nich C, O'Connor PG, Eagan DA, Frankforter TL, Triffleman EG, Shi J, Rounsaville BJ.

Arch Gen Psychiatry. 2001 Aug;58(8):755-61.

13.

Improvement in naltrexone treatment compliance with contingency management.

Preston KL, Silverman K, Umbricht A, DeJesus A, Montoya ID, Schuster CR.

Drug Alcohol Depend. 1999 Apr 1;54(2):127-35.

PMID:
10217552
14.

Can psychotherapy rescue naltrexone treatment of opioid addiction?

Rounsaville BJ.

NIDA Res Monogr. 1995;150:37-52. No abstract available.

PMID:
8742771
15.

Network therapy for addiction: a model for office practice.

Galanter M.

Am J Psychiatry. 1993 Jan;150(1):28-36. Review.

PMID:
8417577
16.

A structured interview guide for the Hamilton Depression Rating Scale.

Williams JB.

Arch Gen Psychiatry. 1988 Aug;45(8):742-7.

PMID:
3395203
17.

A behavioral approach to achieving initial cocaine abstinence.

Higgins ST, Delaney DD, Budney AJ, Bickel WK, Hughes JR, Foerg F, Fenwick JW.

Am J Psychiatry. 1991 Sep;148(9):1218-24.

PMID:
1883001
18.

Effects of contingent payment on compliance with a naltrexone regimen.

Grabowski J, O'Brien CP, Greenstein R, Ternes J, Long M, Steinberg-Donato S.

Am J Drug Alcohol Abuse. 1979;6(3):355-65.

PMID:
539577
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk